CDC Delays COVID Vaccine Orders Amid Leadership Shakeup
CDC delays COVID-19 vaccine purchases for federal programs without clear public explanation.
Why it matters: Legal professionals in healthcare regulation should note altered federal vaccine procurement under RFK Jr., affecting compliance and access for millions of children.
- CDC delays COVID-19 vaccine distribution through the Vaccines for Children program, impacting over half of U.S. children eligible for free vaccines.
- Eleven states and one U.S. territory are affected by a pause in the universal vaccine purchase program tied to VFC contracts.
- HHS Secretary Robert F. Kennedy Jr. stated procurement decisions aim to ensure vaccines are appropriate but did not specify criteria.
- In June 2025, RFK Jr. dismissed the CDC's entire 17-member Advisory Committee on Immunization Practices over alleged conflicts of interest.
The Centers for Disease Control and Prevention (CDC) has delayed COVID-19 vaccine purchases through the federally funded Vaccines for Children (VFC) program. This program covers approximately 52% of children in the U.S., providing free vaccines to eligible minors regardless of insurance.
Additionally, this pause impacts 11 states and one U.S. territory participating in a universal vaccine purchase program, which buys vaccines through VFC contracts to provide coverage for all children in those regions.
The delay follows leadership changes initiated by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who took office in early 2025. The CDC has not publicly clarified the specific reasons behind the unsettled procurement decisions for the VFC and the Section 317 program, which historically funds vaccines for underserved populations. An HHS official told Ars Technica that the department is "ensuring the vaccines purchased are appropriate for the populations they serve," but details on the criteria or timeline remain undisclosed.
Most notably, in June 2025, Secretary Kennedy dismissed all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP). Kennedy cited concerns about conflicts of interest and asserted the need to "restore public trust" in vaccine policymaking. This committee traditionally sets vaccine policy recommendations that influence federally funded programs and public health guidance.
Earlier, in May 2025, Kennedy also announced the removal of COVID-19 vaccines for healthy children and pregnant women from the CDC’s recommended immunization schedule, intensifying uncertainty about official vaccine guidance.
For legal professionals specializing in healthcare regulation, these developments may signal shifting standards in federal vaccine oversight, procurement transparency, and regulatory accountability. The delays and governance changes could also affect litigation risks and compliance obligations for stakeholders relying on federally distributed vaccines.
By the numbers:
- 52% — Percentage of U.S. children eligible for free vaccines through the VFC program affected by delays
- 17 — Number of CDC Advisory Committee on Immunization Practices members dismissed in June 2025
What's next: Monitoring is ongoing for new vaccine procurement policies and replacement advisory committees following ACIP's dismissal.